Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Explained | What is the National Medical Devices Policy, 2023?

Explained | What is the National Medical Devices Policy, 2023?

The Hindu
Monday, May 22, 2023 10:51:08 AM UTC

On April 26, the Union Cabinet approved the National Medical Devices Policy, 2023.Here are the various reasons why it is imporetant

The story so far: On April 26, the Union Cabinet approved the National Medical Devices Policy, 2023. The policy endeavours to facilitate an orderly growth of the sector and in turn, achieve the public health objectives of access, affordability, quality and innovation. It is expected to help the domestic medical devices sector market grow from $11 billion to $50 billion by 2030 alongside achieving a 10-12% global market share over the next 25 years. The aim is to provide the required support and direction, and help the sector become “competitive, self-reliant, resilient and innovative” to cater not only to domestic but global needs.  

The most significant of the introduced measures entail regulatory streamlining. The policy enhances the role of the Bureau of Indian Standards (BIS) along with designing a coherent pricing regulation.  

Pricing regulation is particularly important for addressing a broader challenge in the domestic device manufacturing sector. Rajiv Nath, Forum Coordinator at the Association of Indian Medical Devices Manufacturers (AiMeD) told The Hindu that some private hospitals give higher priced products instead of available low-cost options.

“Because of this, the manufacturer or importer of India is tied up in a system of market operating with artificially inflated MRP labelled on the device,” said Mr. Nath, adding separately, “we have been seeking MRP of imports be monitored and compared with imports’ landed prices and steps taken to control when found irrationally excessive.”  

He was optimistic that the policy would enable monitoring of prices and curbing of such practices.

Besides capping prices, the streamlining endeavour will also create a single window clearance system for licensing of medical devices, combining relevant departments like the Atomic Energy Regulatory Board (AERB), MeitY and the Department of Animal Husbandry and Dairying (DAHD). 

To ensure a skilled workforce and create future ready MedTech human resources, comprising scientists, regulators, health experts, managers, and technicians, the policy would support dedicated multidisciplinary courses for medical devices, including futuristic medical technologies, high-end manufacturing and research.

Read full story on The Hindu
Share this story on:-
More Related News
Government to release new series of retail inflation, GDP data from February, IIP from May next year

The Indian government will release new macroeconomic data series, including GDP and inflation, starting February 2026.

Granules’ generic for ADHD secures U.S. FDA tentative nod

Granules India secures U.S. FDA tentative approval for its ADHD generic, enhancing access to critical therapy and expanding its generics portfolio.

Italy regulator fines Apple $115 million for alleged App Store privacy violations

Italy’s competition authority (AGCM) ‍said on Monday it had fined ​U.S technology giant Apple and two of ‌its divisions 98.6 million ​euros ($115.53 million) over alleged abuse of their dominant position in the mobile app market.

No duty concessions by India on dairy sector for New Zealand under trade pact

India denies duty concessions on dairy imports from New Zealand in recent trade pact negotiations, prioritizing local farmers' protection.

Zero-duty market access to Indian exports, pledge to invest $20 billion, and more: Highlights of India-New Zealand free trade agreement

India-New Zealand free trade agreement offers zero-duty access, $20 billion investment pledge, and enhanced trade in multiple sectors.

India, New Zealand announce conclusion of FTA negotiations

India and New Zealand finalise a trade deal, enhancing exports and fostering economic growth between the two nations.

Stock markets surge in early trade on foreign fund inflows, firm global trends

Stock markets rise as foreign fund inflows boost investor confidence, with major gains from Infosys, Tata Steel, and Tech Mahindra.

Netflix and Paramount are fighting over Warner Bros. Discovery

Warner Bros. Discovery is in the middle of a Hollywood tug-of-war between Netflix and Paramount.

When ‘misvestment’ has more facets than is known Premium

Explore the pitfalls of misvestment and discover how to make informed investment decisions for long-term wealth growth.

M-cap of 6 of top-10 most valued firms climbs ₹75,257 crore; TCS, Infosys biggest winners

Market valuations of top firms rose by ₹75,257 crore, with TCS and Infosys leading the gains last week.

IIFL Finance appoints ex-RBI Deputy Governor B. P. Kanungo as chairman

IIFL Finance appoints ex-RBI Deputy Governor B. P. Kanungo as chairman, enhancing governance and strategic direction for stakeholders.

SEBI group to review non-agricultural derivatives

SEBI plans to form a working group to enhance liquidity and review non-agricultural commodity derivatives, boosting market attractiveness.

Agnikul’s $17 million fundraise signals ‘maturing investor confidence in India’s space sector’

Space sector opened up to private participation in June 2020

RBI announces fresh measures to inject ₹2.90 lakh crore liquidity 

RBI announces ₹2.90 lakh crore liquidity measures to stabilize markets and address dollar liquidity concerns.

Sensex slips 42 points after two-day rally; IT shares fall on profit-taking

Sensex drops 42 points after two-day rally as IT shares face profit-taking amidst mixed global market cues.

Chola Investment trashes corporate misgovernance allegations as malicious, baseless

Cholamandalam Investment dismisses Cobrapost's misgovernance allegations as baseless, reaffirming commitment to compliance and transparency.

Gold prices, silver futures extend record rally on rate-cut hopes

Gold and silver prices surge to record highs as investors seek safe havens amid geopolitical tensions and rate-cut expectations.

Stock markets decline in early trade after two days of rally

Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.

Rupee falls 5 paise to 89.73 against U.S. dollar in early trade

Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.

Mercedes-Benz agrees to pay $149.6 million to settle multistate emissions allegations

Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.

U.S. FDA approves Wegovy pill for weight loss

U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.

Overall economic activity has held up with demand conditions remaining robust: RBI Bulletin

RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.

Biofabri, Bharat Biotech ink tech transfer pact for MTBVAC tuberculosis vaccine

Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.

Expecting bilateral trade with New Zealand to double in five years with FTA: Piyush Goyal

India anticipates doubling trade with New Zealand to $5 billion in five years following a historic women-led free trade agreement.

Rupee falls 3 paise to close at 89.70 against U.S. dollar

Rupee dips 3 paise to 89.70 against the dollar amid trade deal concerns and rising crude oil prices.

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us